Iron oxide-based nanovector for tumor targeted siRNA delivery in an orthotopic hepatocellular carcinoma xenograft mouse model

Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide. Small interfering RNA (siRNA) holds promise as a new class of therapeutics for HCC as it can achieve sequence-specific gene knockdown with low cytotoxicity. However, the main challenge in the clinical application of siRNA lies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Small
Main Authors: Wang, Kui, Kievit, Forrest M., Sham, Jonathan G., Jeon, Mike, Stephen, Zachary R., Bakthavatsalam, Arvind, Park, James O., Zhang, Miqin
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829640/
https://ncbi.nlm.nih.gov/pubmed/26641029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201501985
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados